ArchCare MA

Contract: H8312 · Plan type: HMO

Evidence lead: Bottom-seven record · Low appeal-filing share

ArchCare MA: Only a small share of denials entered appeal

381 appeals correspond to 15.0% of the plan's denied requests. That is rank #35 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.

Bottom-seven record · Low appeal-filing share

Only a small share of denials entered appeal

381 appeals correspond to 15.0% of the plan's denied requests. That is rank #35 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.

Bottom-seven record · Smaller request-volume cohort

One of the narrower authorization records

The source records 41,000 requests here, placing the contract in the smallest-volume tier. Its request-volume rank is #33 of 37. Volume shows the denominator behind approvals and denials; it is not a measure of plan quality, membership, benefit breadth, price, or future coverage decisions.

Ranks twenty-six through thirty · Lower-middle denial cohort

Below the center of the denial-rate ordering

At 6.2%, this contract sits in the lower-middle part of the observed distribution. The exact rank is #26 of 37. This is aggregate prior-authorization activity for the reporting window, not a probability that a particular service, drug, or beneficiary request will be denied.

Ranks eleven through fifteen · Upper-middle overturn cohort

Appeal overturns ran above most contracts

The observed overturn rate is 74.0%, in the upper-middle portion of the table. Its overturn-rate rank is #12 of 37. The denominator is filed appeals, not all authorization requests. The percentage therefore describes reviewed appeals and must not be read as an individual outcome forecast.

Ranks eleven through fifteen · Upper-middle reversal reach

Reversals covered an above-median share of denials

Overturned appeals represent 11.1% of all denials here, based on 282 reversals. The cross-contract rank is #13 of 37. This derived measure combines appeal filing and outcome, so it supplies scale context but does not identify clinical reasons, administrative errors, or coverage rules.

Prior Authorization Scorecard

PA Requests
41,000
PA Denial Rate
6.2%
Appeals Filed
381
Appeal Overturn Rate
74.0%

Detailed Metrics

Metric Value
Prior Authorization Requests 41,000
PA Approved 38,458
PA Denied 2,542
Appeals Filed 381
Appeals Overturned 282
Source: CMS Office of Inspector General report OEI-09-22-00380; KFF 2023 Medicare Advantage analysis. Verify with HHS OIG → · CMS.gov →
Sources, caveats, and related notes for ArchCare MA
What does ArchCare MA's overturn rate mean? Of the appeals filed after denials in this source record, 74% were overturned (282 of 381 filed appeals, not all 2,542 denied requests).
This data is for informational purposes only and does not constitute medical, financial, or insurance advice. Contact CMS or your plan for coverage decisions. Data from CMS OIG and KFF Medicare Advantage analysis.

Data: CMS OIG OEI-09-22-00380 and KFF 2023 Medicare Advantage analysis. Not affiliated with CMS. ← All MA plans

Read our methodology - how this data is sourced, computed, and verified.

Primary data: U.S. Department of Health & Human Services, Office of Inspector General, Medicare Advantage Encounter Data (Report OEI-09-22-00380, 2024). Secondary data: Kaiser Family Foundation 2023 Medicare Advantage Prior Authorization analysis. Methodology and editorial review by PlainInsurer, see methodology.